YI News and Press, 111 Inc.

111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024 PR Newswire SHANGHAI July 17, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the ...

2024-06-11 04:59:50 ET More on 111 111, Inc. (YI) Q1 2024 Earnings Call Transcript 111, Inc. (YI) Q4 2023 Earnings Call Transcript Financial information for 111 Read the full article on Seeking Alpha For further details see: China's 111 and Scrian...

111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility PR Newswire SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare plat...

2024-05-23 13:33:01 ET 111, Inc. (YI) Q1 2024 Earnings Conference Call May 23, 2024, 07:30 AM ET Company Participants Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO, 111's Major Subsidiary Haihui Wang - COO Conference Call Participants P...

2024-05-23 04:59:47 ET More on 111 Financial information for 111 Read the full article on Seeking Alpha For further details see: 111 Non-GAAP EPADS of -$0.02, revenue of $488.68M

111, Inc. Announces First Quarter 2024 Unaudited Financial Results PR Newswire Turned to Quarterly Operational Profitability for the First Time Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% Achieved Positive Operating C...

111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow PR Newswire SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company co...

2024-03-21 15:23:03 ET 111, Inc. (YI) Q4 2023 Earnings Conference Call March 21, 2024 07:30 ET Company Participants Junling Liu - Co-Founder, Chairman & Chief Executive Officer Luke Chen - Chief Financial Officer of 111's Major Subsidiary Conference Call Pa...

X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...

2024-03-21 05:10:29 ET More on 111 Financial information for 111 Read the full article on Seeking Alpha For further details see: 111 Non-GAAP EPADS of -$0.08, revenue of $578.7M